REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/22/2026
Back to search
Official data from USPTO
NOGRA PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
06/23/2026
Trademark type
Word
Nice classes
5
Filing date
10/22/2020
Registration date
06/22/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/22/2021
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
77
Owner location
Dublin 2, IE
Examiner
REINHART, MEGHAN M
Law office
L80
Current location
PETITIONS OFFICE
Holders and representatives
Holders
Nogra Pharma Limited
Representatives
Michael A. Marrero ULMER & BERNE LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of immune-system-related diseases and disorders and inflammatory disordersgastrointestinal diseases and disorders and skin disorders
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/22/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
05/15/2021
APET
ASSIGNED TO PETITION STAFF
05/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2021
PUBO
PUBLISHED FOR OPPOSITION
04/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/17/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
03/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/01/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/27/2021
GNRT
NON-FINAL ACTION E-MAILED
02/27/2021
CNRT
NON-FINAL ACTION WRITTEN
02/27/2021
DOCK
ASSIGNED TO EXAMINER
02/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2020
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
10/27/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/27/2020
NWAP
NEW APPLICATION ENTERED
10/26/2020
Continuous trademark protection
Get notified about every new filing that threatens NOGRA PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.